Our approach involves a proprietary multiparametric assessment that integrates molecular datasets with clinical, competitive and market data into our knowledge graph. This allows us to develop and validate robust prediction models to inform strategic decisions.
What we offer
Specific product strategy
-
Understand new indications in the context of specific product strategy
-
Advise planning for primary research, such as choice of patient-reported outcome instruments and comparators
-
Estimate clinical comparisons of products versus competitors
-
Capitalize on existing research while assessing evidence gaps
-
Provide information for value development planning
Discover Impactful Work for Target Identification
-
Identify and prioritise the most fitting and attractive biological targets for a technology platform of interest
-
Define and refine research questions as they pertain to the SLR objectives
-
Design of search strings and algorithms to be implemented in scientific literature databases (PubMed, EMBASE, Cochrane, etc.) and grey literature
-
Develop inclusion/exclusion criteria within the PICOS framework
Evidence evaluation
-
Synthesise and evaluate the evidence necessary in a timely and strategic manner to maximise the commercial value of product(s) by demonstrating product differentiation and economic value.
-
Develop and execute advanced analytic methods in the assessment of real-world evidence and insights
-
Generate evidence-based therapeutic guidelines
-
Participate in non-literature-based research and consulting activities within stakeholders
Discovery science and disease mapping
-
Evaluate the current state, future scenarios and opportunities of an indication or therapeutic area of interest
-
Conduct laboratory research related to drug efficacy and development of formulations suitable for pre-clinical use
-
Support preclinical drug delivery platforms and efficacy studies related to animal disease models
-
Work with external collaborators and Contract Research Organisations for timely execution of projects.
-
Draft new project proposals for internal R&D and extramural funding.
Drug repurposing
-
Conduct multiparametric analyses to identify druggable pathways and mechanism-based targets of disease
-
Utilise in silico approaches to identify molecules for drug repurposing
-
Design experimental verification to leverage key drug discovery and development insights
-
Coordinate pre-clinical studies and, where possible, translational and clinical trials
-
Provide regulatory guidance, related to repurposed drugs and combination products.
Synthesis and modelling
-
Conduct domain-specific and Bayesian modelling and simulation to support biomedical decision making
-
Apply models to support decision-making through Monte-Carlo simulation
-
Perform model-based meta-analysis of therapeutic area summary-level data
-
Conduct MBMA analyses to address client’s key drug development questions
-
Design and execute quantitative research such as economic evaluations, cost-effectiveness analyses, budget impact models, comparative effectiveness tests
Get a quote
​
73 London road, Suite 31
Liverpool L3 8HY
United Kingdom
+44 745 3418908